Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | DGKA | P23743 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.39 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 1/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL548470 | 1.00 | MEN1 (0.45) | MEN1MAPTKMT2AATML3MBTL1 | |
| SCHEMBL4341048 | 0.98 | MEN1 (0.42) | MEN1MAPTKMT2AATML3MBTL1 | |
| Heptane SCHEMBL6925620 | 0.86 | NAAA (0.40) | MEN1MAPTKMT2AATML3MBTL1 | |
| SCHEMBL9309086 | 0.83 | MEN1 (0.43) | MEN1MAPTKMT2AATML3MBTL1 | |
| Hexane SCHEMBL9472263 | 0.81 | GAA (0.44) | MEN1MAPTKMT2AATML3MBTL1 | |
| SCHEMBL19861329 | 0.80 | FFAR1 (0.48) | MEN1MAPTKMT2AATML3MBTL1 | |
| SCHEMBL20457453 | 0.80 | FFAR1 (0.48) | MEN1MAPTKMT2AATML3MBTL1 | |
| SCHEMBL5864262 | 0.79 | GAA (0.43) | GAAMGAMSIMGAM2CYP4F2 | |
| SCHEMBL11209470 | 0.79 | MEN1 (0.45) | MEN1MAPTKMT2AATML3MBTL1 | |
| SCHEMBL19861159 | 0.79 | MEN1 (0.49) | MEN1MAPTKMT2AATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12012411-B2 | Viral replication inhibitors | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2024-06-18 | — | — | US | disclosed |
| CN-116332999-A | Organic electroluminescent material and device | 环球展览公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-108440370-B | Inhibitors of viral replication | 鲁汶天主教大学 | 2021-07-30 | — | — | CN | disclosed |
| EP-3617192-A1 | VIRAL REPLICATION INHIBITORS | Katholieke Universiteit Leuven K.U. Leuven R&D (BE) | 2020-03-04 | — | — | EP | disclosed |
| US-10550123-B2 | Viral replication inhibitors | KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) | 2020-02-04 | — | — | US | disclosed |
| US-20190337954-A1 | VIRAL REPLICATION INHIBITORS | KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) | 2019-11-07 | — | — | US | disclosed |
| EP-2760831-B1 | VIRAL REPLICATION INHIBITORS | UNIV LEUVEN KATH (BE) | 2019-08-07 | — | — | EP | disclosed |
| CN-104024223-A | Inhibitors of viral replication | UNIV LEUVEN KATH | 2014-09-03 | — | — | CN | disclosed |
| EP-2760831-A1 | VIRAL REPLICATION INHIBITORS | Katholieke Universiteit Leuven (BE) | 2014-08-06 | — | — | EP | disclosed |
| US-20140213586-A1 | VIRAL REPLICATION INHIBITORS | KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) | 2014-07-31 | — | — | US | disclosed |
| EP-0577191-B1 | Photographic element and process comprising a bleach accelerator releasing compound and methods of making such compound | EASTMAN KODAK CO (US) | 1997-05-21 | — | — | EP | disclosed |
| EP-0751425-A1 | Photographic element containing a coupler capable of releasing a photographically useful group | EASTMAN KODAK COMPANY (US) | 1997-01-02 | — | — | EP | disclosed |
| US-5358828-A | Coupler capable of forming wash-out dye | EASTMAN KODAK COMPANY (US) | 1994-10-25 | — | — | US | disclosed |
| US-5318879-A | Photographic element comprising a bleach accelerator releasing compound | EASTMAN KODAK COMPANY (US) | 1994-06-07 | — | — | US | disclosed |
| US-5300406-A | Coupler which forms dye that washes out during processing | EASTMAN KODAK COMPANY (US) | 1994-04-05 | — | — | US | disclosed |
| US-5286859-A | Bleach accelerating releasing coupler; forming chloroformate with phosgene, reacting with a thiol | EASTMAN KODAK COMPANY (US) | 1994-02-15 | — | — | US | disclosed |
| EP-0577190-A2 | Photographic element comprising a bleach accelerator releasing compound containing an acid solubilizing group | EASTMAN KODAK COMPANY (US) | 1994-01-05 | — | — | EP | disclosed |
| EP-0577193-A1 | Photographic element comprising a combination of a development inhibiting releasing coupler and a bleach accelerator releasing compound | EASTMAN KODAK COMPANY (US) | 1994-01-05 | — | — | EP | disclosed |
| EP-0577191-A2 | Photographic element and process comprising a bleach accelerator releasing compound and methods of making such compound | EASTMAN KODAK COMPANY (US) | 1994-01-05 | — | — | EP | disclosed |
| EP-0577192-A1 | Photographic element comprising a dir coupler and a barc coupler containing an acid solubilizing group | EASTMAN KODAK COMPANY (US) | 1994-01-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140213586-A1 | VIRAL REPLICATION INHIBITORS | EIF2AK2, MAVS, ZC3HAV1 | MEN1 3390/4885MAPT 3097/4885KMT2A 2425/4885 |
| US-20190337954-A1 | VIRAL REPLICATION INHIBITORS | EIF2AK2, MAVS, ZC3HAV1 | MEN1 3390/4885MAPT 3097/4885KMT2A 2425/4885 |
| US-10550123-B2 | Viral replication inhibitors | EIF2AK2, MAVS, ZC3HAV1 | MEN1 3390/4885MAPT 3097/4885KMT2A 2425/4885 |
| US-12012411-B2 | Viral replication inhibitors | EIF2AK2, MAVS, ZC3HAV1 | MEN1 3390/4885MAPT 3097/4885KMT2A 2425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.